Topic | Opening | Deadline |
IHI Joint Undertaking
|
Improved prediction, detection, & treatment approaches for comprehensive stroke management (RIA) | 27-Jul-23 | 16-Jan-24
|
Development & proof of principle of new clinical applications of theranostics solutions (RIA) | 27-Jul-23 | 16-Jan-24 |
Maximising the potential of synthetic data generation in healthcare applications (RIA) | 27-Jul-23 | 16-Jan-24 |
Accelerating the implementation of New Approach Methodologies & other innovative non-animal approaches for the | 27-Jul-23 | 16-Jan-24 |
development, testing & production of health technologies (RIA) |
Inclusive clinical studies for equitable access to clinical research in Europe (two-stage, RIA) | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
Safe & Sustainable by Design (SSbD) packaging & single use device solutions for healthcare products (RIA) | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
Patient-centric blood sample collection to enable decentralised clinical trials & improve access to healthcare (RIA) | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
Establishing novel approaches to improve clinical trials for rare & ultra-rare diseases (RIA) | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
Expanding translational knowledge in minipigs: a path to reduce & replace non-human primates in non-clinical safety | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
assessment (RIA) |
Sustainable circular development & manufacturing of healthcare products & their quantitative environmental impact | 27-Jul-23 | 08-Nov-23 23-Apr-24 |
assessment (RIA) |
Destination 3. Tackling disease & reducing disease burden
|
Pandemic preparedness & response: Maintaining the European partnership for pandemic preparedness (CSA) | 26-Oct-23 | 11-Apr-24
|
Pandemic preparedness & response: Host-pathogen interactions of infectious diseases with epidemic potential (RIA) | 26-Oct-23 | 11-Apr-24 |
European Partnership: One Health Anti-Microbial Resistance (Cofund) | 25-Apr-24 | 25-Sep-24 |
|
Bio-printing of living cells for regenerative medicine (IA) | 26-Oct-23 | 11-Apr-24
|
Destination 6. Maintaining an innovative, sustainable & globally competitive health industry
|
Developing EU methodological frameworks for clinical/performance evaluation & post-market clinical/performance follow-up | 26-Oct-23 | 11-Apr-24
|
of medical devices & in vitro diagnostic medical devices (IVDs) (RIA) |
Gaining experience & confidence in New Approach Methodologies (NAM) for regulatory safety & efficacy testing – | 26-Oct-23 | 11-Apr-24 |
coordinated training & experience exchange for regulators (CSA) |